Firefly Neuroscience (AIFF) Cost of Revenue (2010 - 2026)

Firefly Neuroscience's Cost of Revenue history runs 16 years deep, the most recent figure standing at $264000.0 for Q1 2026.

• On a quarterly basis, Cost of Revenue changed N/A year-over-year to $264000.0 in Q1 2026; TTM through Mar 2026 was $761000.0, a 37.42% decrease from a year earlier, with the FY2025 full-year figure at $497000.0, changed N/A from the prior year.
• Cost of Revenue grew to $264000.0 in Q1 2026 per AIFF's latest filing, from $230000.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.8 million in Q2 2022 and bottomed at $25000.0 in Q2 2025.
• The 5-year median for Cost of Revenue is $1.3 million (2023), against an average of $1.2 million.
• Across the five-year window, Cost of Revenue retreated 4.2% in 2022 and slumped 53.64% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $1.4 million in 2022, then fell by 15.16% to $1.2 million in 2023, then decreased by 0.91% to $1.2 million in 2024, then tumbled by 81.09% to $230000.0 in 2025, then rose by 14.78% to $264000.0 in 2026.
• Per Business Quant, the three latest AIFF Cost of Revenue figures stand at $264000.0 (Q1 2026), $230000.0 (Q4 2025), and $242000.0 (Q3 2025).